Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene AlterationsJohn Tyhonas, Stephen W. Kaldor, Elisabeth Gardiner et al.|Journal of Medicinal Chemistry|2024Cited by 18
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations.Aleksandra Franovic, Eric S. Martin, Adithi Mohan et al.|Journal of Clinical Oncology|2022Cited by 8